Alaunos Therapeutics Inc
TCRT2.690USD
+0.060+2.28%
收盤 02/09, 16:00（美東）報價延遲15分鐘
1.43M總市值
虧損本益比TTM
關於 Alaunos Therapeutics Inc 公司
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.
Alaunos Therapeutics Inc簡介
公司代碼TCRT
公司名稱Alaunos Therapeutics Inc
上市日期Aug 20, 2004
CEOWeis (Holger)
員工數量1
證券類型Ordinary Share
年結日Aug 20
公司地址501 E Las Olas Blvd
城市FORT LAUDERDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33301
電話13463554099
網址https://alaunos.com/
公司代碼TCRT
上市日期Aug 20, 2004
CEOWeis (Holger)
Alaunos Therapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Ferdinand Groenewald
Mr. Ferdinand Groenewald
Vice President - Finance
Vice President - Finance
10.78K
+10775.00%
Mr. Holger Weis, CPA
Mr. Holger Weis, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.21K
--
Mr. Jaime W. Vieser
Mr. Jaime W. Vieser
Independent Director
Independent Director
--
--
Mr. Robert W. Postma
Mr. Robert W. Postma
Independent Director
Independent Director
--
--
Mr. Michael Jerman
Mr. Michael Jerman
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Ferdinand Groenewald
Mr. Ferdinand Groenewald
Vice President - Finance
Vice President - Finance
10.78K
+10775.00%
Mr. Holger Weis, CPA
Mr. Holger Weis, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.21K
--
Mr. Jaime W. Vieser
Mr. Jaime W. Vieser
Independent Director
Independent Director
--
--
Mr. Robert W. Postma
Mr. Robert W. Postma
Independent Director
Independent Director
--
--
Mr. Michael Jerman
Mr. Michael Jerman
Director
Director
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 1月31日 週六
更新時間: 1月31日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Vieser (Jaime W.)
1.99%
Postma (Robert W.)
1.97%
Watermill Asset Management
1.49%
The Vanguard Group, Inc.
1.35%
BlackRock Institutional Trust Company, N.A.
0.96%
其他
92.24%
持股股東
持股股東
佔比
Vieser (Jaime W.)
1.99%
Postma (Robert W.)
1.97%
Watermill Asset Management
1.49%
The Vanguard Group, Inc.
1.35%
BlackRock Institutional Trust Company, N.A.
0.96%
其他
92.24%
股東類型
持股股東
佔比
Individual Investor
5.13%
Investment Advisor
3.95%
Investment Advisor/Hedge Fund
0.72%
Hedge Fund
0.07%
Bank and Trust
0.06%
Research Firm
0.03%
其他
90.04%
機構持股
更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
118
107.75K
4.83%
-130.28K
2025Q3
134
104.76K
4.77%
-152.44K
2025Q2
153
252.84K
13.09%
-146.73K
2025Q1
169
296.91K
17.46%
-90.28K
2024Q4
182
298.15K
18.62%
-116.62K
2024Q3
208
422.39K
26.38%
-38.04K
2024Q2
224
471.36K
29.44%
+11.94K
2024Q1
281
305.54K
19.08%
-201.69K
2023Q4
302
346.05K
21.58%
-260.76K
2023Q3
324
525.07K
33.28%
-179.72K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Vieser (Jaime W.)
38.67K
1.73%
+5.34K
+16.02%
Nov 21, 2025
Postma (Robert W.)
38.29K
1.72%
+5.14K
+15.51%
Nov 21, 2025
Watermill Asset Management
33.33K
1.49%
+33.33K
--
Jun 24, 2025
The Vanguard Group, Inc.
20.97K
0.94%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
21.35K
0.96%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
15.79K
0.71%
-155.00
-0.97%
Sep 30, 2025
Groenewald (Ferdinand)
10.78K
0.48%
+10.78K
--
Aug 18, 2025
Jerman (Michael Allen)
4.18K
0.19%
+4.18K
--
Nov 21, 2025
Hogue (Dale Curtis Jr.)
4.44K
0.2%
+442.00
+11.05%
Apr 30, 2025
Morgan Stanley Smith Barney LLC
1.68K
0.08%
-58.00
-3.33%
Sep 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
Jul 16, 2024
Merger
10→1
Jul 16, 2024
Merger
10→1
Jul 16, 2024
Merger
10→1
Jul 16, 2024
Merger
10→1
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
公告日期
除權除息日
類型
比率
Jul 16, 2024
Merger
10→1
Jul 16, 2024
Merger
10→1
Jul 16, 2024
Merger
10→1
Jul 16, 2024
Merger
10→1
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
Jan 29, 2024
Merger
15→1
